Only one-fifth believe that if they were diagnosed with cancer today, all their medications would be covered by their province’s healthcare system or medical insurance1 TORONTO, June 14, 2012 /CNW/ – Ontarians
The U.S. Preventative Services Task Force (USPSTF) recommendation against the use of Prostate-Specific Antigen (PSA) blood tests sets a dangerous precedent for all patients seeking preventative measures in the fight against cancer.
Remembering Maureen By Jackie Manthorne Maureen died on May 17, 2012 after a valiant battle with pulmonary fibrosis. She was the loving mother of Natalie and her husband Brent Pilon, and Steve
May 22, 2012
Attend a Town Hall Meeting – Nine towns remaining in the Ontario Health Coalition’s Cross-Province Tour
This is a reminder of the upcoming town hall meetings near you. As you know, the recent “austerity budget” threatens more cuts to hospitals and health services all across Ontario. All concerned
May 22, 2012
ZYTIGA® Now Available for Eligible Patients in Nova Scotia and Newfoundland and Labrador
Provinces are fifth and sixth in Canada to reimburse new metastatic prostate cancer treatment Toronto, ON (May 16, 2012) – Men living with metastatic prostate cancer in Nova Scotia and Newfoundland and
May 18, 2012
ZYTIGA™* (abiraterone acetate) receives Health Canada approval for treatment for metastatic prostate cancer
First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources Toronto, ON, July 28, 2011– Janssen Inc. announced today that after a priority review, Health Canada has